Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Rapport Therapeutics to Present New Phase 2a Data Analysis Further Characterizing RAP-219 in Focal Onset Seizures at 2025 American Epilepsy Society Annual Meeting
-
Denodo Named as a Leader in IDC MarketScape for Data Integration Software Platforms
-
Pasithea Therapeutics Announces $1 Million Award by ALS Association to Study the Efficacy, Safety, and Tolerability of PAS-004 for Treatment of ALS
-
Colliers named World’s Best Real Estate Adviser for second straight year
-
Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences
-
TeraWulf Announces Mandatory Conversion Date for Series A Convertible Preferred Stock
-
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
C4 Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
-
Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
-
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program
-
OTC Markets Group Welcomes Compass Group PLC to OTCQX
-
Intchains Group to Participate in Two Upcoming Investor Conferences
-
Cronos Launches Premium Lord Jones Live Resin Fusions™ in Canada
-
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Rubico Inc. Announces Time Charter Extensions and Contracted Revenue Backlog of $120.8 Million
-
Purespring Therapeutics to Present at Piper Sandler’s 37th Annual Healthcare Conference
-
Amphista Therapeutics announces new AMX-883 data to be presented at the ASH Annual Meeting and Exposition and provides a business progress update
-
Bitget Launches “Affiliates Boost Month” With Fast-Track Approvals and Up to 5,000 USDT in Rewards
-
Allianz Commercial to launch hub for Latin America in Miami in 2026
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
Forum in Vietnam calls for boosting globalization of traditional Chinese medicine
-
ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference
-
“The Way of White Porcelain – From Dehua to Gubbio” Art Exhibition Opens in Italy, Bridging Civilizations Through Ceramic Art
-
Size of RIKS 26 0216
-
Formulated Materials to Exhibit at World of Concrete 2026; Donates $40,000 to Tunnel to Towers Veterans Villages
-
Titan Machinery Inc. Announces Results for Fiscal Third Quarter Ended October 31, 2025
-
Movado Group, Inc. Announces Third Quarter Fiscal 2026 Results
-
US Foods to Present at the 2025 Morgan Stanley Global Consumer & Retail Conference
-
Burlington Stores, Inc. Reports Third Quarter 2025 Earnings
-
Form 8.3 - Unite Group Plc
-
Form 8.3 - Idox Plc
-
Form 8.3 - Empiric Student Property Plc
-
Ivanhoe Mines Announces Completion of Hydropower Ramp-Up of 178-megawatt Turbine #5 at Inga II
-
The Death of the Password: Will Biometrics Finally Kill the Six-Digit Code?
-
Hexaware Debuts Strongly in Whitelane Research 2025 German IT Sourcing Study
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
Andean Precious Metals Strengthens Balance Sheet with New $40 Million Credit Facility from National Bank of Canada
-
AuMEGA Metals Expands Drill Program
-
OxaPay White-Label: Your Custom Crypto Gateway, Ready in a Day
-
Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance
-
Xoriant Acquires TestDevLab to Expand European Presence & AI-Driven QE Capabilities
-
Henry Schein One Unveils Industry-first Natively Embedded Voice Workflow at 2025 Greater New York Dental Meeting
-
American Woodmark Corporation Announces Second Quarter Results
-
LyondellBasell to address 2025 Goldman Sachs Industrials and Materials Conference
-
Nokia announces delisting from Paris Stock Exchange
-
Babcock & Wilcox to Present at 5th Annual B. Riley Convergence Conference on December 4, 2025
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
Chery's First Transformable 7-Seater SUV Debuts in Indonesia, Offering a New Family Mobility Solution
-
Novo Nordisk phase 2 trial with amycretin reports significant weight loss and HbA1c reduction in type 2 diabetes
-
Fixing of coupon rates - Nykredit Realkredit A/S

